Cargando…

P1043: EFFICACY AND SAFETY OF TRAMETINIB IN ADULTS WITH LANGERHANS CELL HISTIOCYTOSIS AND ERDHEIM-CHESTER DISEASE

Detalles Bibliográficos
Autores principales:	Latyshev, Vitalii, Kostina, Irina, Kovrigina, Alla, Lukina, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431469/ http://dx.doi.org/10.1097/01.HS9.0000971068.43168.5d

Ejemplares similares

A Rare Case of Erdheim-Chester Disease and Langerhans Cell Histiocytosis Overlap Syndrome
por: Nabi, Shahzaib, et al.
Publicado: (2015)

A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge
por: Hashmi, Hamza, et al.
Publicado: (2018)

Diverse cutaneous manifestations of Erdheim-Chester disease in a woman with a history of Langerhans cell histiocytosis
por: Neckman, Julia Pettersen, et al.
Publicado: (2016)

Dabrafenib and Trametinib Treatment for Erdheim-Chester Disease With Brain Stem Involvement
por: Al Bayati, Ahmed, et al.
Publicado: (2018)

Serial assessments of anterior pituitary hormones in a case of mixed histiocytosis representing Langerhans cell histiocytosis overlapping with Erdheim–Chester disease
por: Ito, Kei, et al.
Publicado: (2021)

Urologic Manifestations and Hydronephrosis as Initial Presentation of Erdheim-Chester Disease: A Rare Form of Non-Langerhans Histiocytosis
por: Burke, Skyler E, et al.
Publicado: (2021)

Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis
por: Salama, Hind Abdin, et al.
Publicado: (2021)

Erdheim-Chester disease: a rare histiocytosis (case report and review of the literature)
por: Mehdi, Mahtat El, et al.
Publicado: (2018)

Rationale and efficacy of interleukin-1 targeting in pediatric Erdheim- Chester disease
por: Tran, TA, et al.
Publicado: (2011)

Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019)

Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease
por: Váradi, Zsófia, et al.
Publicado: (2017)

Rare diseases of bone: Erdheim-Chester and Rosai-Dorfman non-Langerhans cell histiocytoses
por: Mavrogenis, Andreas F., et al.
Publicado: (2018)

P1049: CHARACTERISTICS AND OUTCOMES OF CARDIOVASCULAR INVOLVEMENT IN ERDHEIM-CHESTER DISEASE
por: Tawfiq, Reema, et al.
Publicado: (2023)

P1416: THE CLINICAL SPECTRUM AND PROGNOSTIC FACTORS OF ERDHEIM-CHESTER DISEASE
por: Dai, Jia-Wen, et al.
Publicado: (2023)

Endoscopic Transsphenoidal Resection of Suprasellar Histiocytosis in a Patient with Erdheim–Chester Disease: A Case Report
por: HONG, Sukwoo, et al.
Publicado: (2021)

Unusual manifestation of Erdheim-Chester disease
por: Pan, Antony, et al.
Publicado: (2011)

Neurological Involvement in Erdheim-Chester Disease
por: Álvarez-Álvarez, Miriam, et al.
Publicado: (2016)

Kidney Transplantation for Erdheim-Chester Disease
por: Yoo, Jongwon, et al.
Publicado: (2020)

Neurological manifestations of Erdheim–Chester Disease
por: Boyd, Louisa C., et al.
Publicado: (2020)

Clinical Images: Erdheim‐Chester disease
por: Mehta, Rohan, et al.
Publicado: (2021)

Erdheim-Chester disease in children: clinical, radiologic, treatment characteristics of three cases
por: Eyssette-Guerreau, S, et al.
Publicado: (2008)

Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis
por: Aaroe, Ashley, et al.
Publicado: (2023)

Dabrafenib, alone or in combination with trametinib, in BRAF V600–mutated pediatric Langerhans cell histiocytosis
por: Whitlock, James A., et al.
Publicado: (2023)

Erdheim-Chester disease: a case report.
por: Park, Y. K., et al.
Publicado: (1999)

Erdheim-Chester Disease: A Case Report
por: Alexiou, Jean, et al.
Publicado: (2015)

Erdheim Chester Disease treated successfully with cladribine
por: Azadeh, Natalya, et al.
Publicado: (2016)

Erdheim — Chester disease: Clinical pearls for the anesthesiologist
por: Hariharan, Uma, et al.
Publicado: (2014)

Isolated pulmonary involvement in Erdheim–Chester disease
por: Josan, Enambir Singh, et al.
Publicado: (2017)

Erdheim-Chester disease with isolated neurological involvement
por: Loureiro, Bruna Melo Coelho, et al.
Publicado: (2018)

A possible case of Erdheim–Chester Disease
por: Martiniuc, Georgeta, et al.
Publicado: (2018)

Erdheim-Chester Disease: The Importance of Information Integration
por: Nikonova, Anna, et al.
Publicado: (2017)

Multisystem Radiologic Manifestations of Erdheim-Chester Disease
por: Lodhi, Umairullah, et al.
Publicado: (2016)

A Diagnostic Challenge: Erdheim Chester Disorder
por: Razi, Mairah, et al.
Publicado: (2019)

Prevalence of Hypothyroidism in Patients With Erdheim-Chester Disease
por: Shekhar, Skand, et al.
Publicado: (2020)

Erdheim-Chester Disease With Concurrent Lung Adenocarcinoma
por: Solomon, Nadia, et al.
Publicado: (2020)

Multimodal Chorioretinal Imaging in Erdheim-Chester Disease
por: Sacconi, Riccardo, et al.
Publicado: (2020)

Erdheim-chester disease revealed by diabetes insipidus
por: Amor, Bilel Ben, et al.
Publicado: (2019)

P1122: EFFICACY OF ALPELISIB IN PI3K-DRIVEN LANGERHANS CELL HISTIOCYTOSIS
por: Mazor, R., et al.
Publicado: (2022)

Erdheim-Chester Disease: a comprehensive review of the literature
por: Mazor, Roei D, et al.
Publicado: (2013)

A Case of Incidentally-diagnosed Erdheim-Chester Disease
por: Dave, Atman A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nd7ju3noc7ve1uou5gkd6eoold